nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—CYP1A2—chronic obstructive pulmonary disease	0.349	1	CbGaD
Nelfinavir—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0458	0.1	CbGbCtD
Nelfinavir—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0432	0.0947	CbGbCtD
Nelfinavir—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0345	0.0755	CbGbCtD
Nelfinavir—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0345	0.0755	CbGbCtD
Nelfinavir—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0287	0.0628	CbGbCtD
Nelfinavir—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0287	0.0628	CbGbCtD
Nelfinavir—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0271	0.0593	CbGbCtD
Nelfinavir—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0262	0.0574	CbGbCtD
Nelfinavir—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0262	0.0574	CbGbCtD
Nelfinavir—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0234	0.0512	CbGbCtD
Nelfinavir—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.022	0.0482	CbGbCtD
Nelfinavir—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0217	0.0476	CbGbCtD
Nelfinavir—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0149	0.0325	CbGbCtD
Nelfinavir—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0145	0.0317	CbGbCtD
Nelfinavir—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0142	0.031	CbGbCtD
Nelfinavir—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0126	0.0277	CbGbCtD
Nelfinavir—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0124	0.0271	CbGbCtD
Nelfinavir—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0117	0.0256	CbGbCtD
Nelfinavir—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00741	0.0162	CbGbCtD
Nelfinavir—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.007	0.0153	CbGbCtD
Nelfinavir—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000315	0.00209	CcSEcCtD
Nelfinavir—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.00209	CcSEcCtD
Nelfinavir—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00208	CcSEcCtD
Nelfinavir—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00208	CcSEcCtD
Nelfinavir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000311	0.00206	CcSEcCtD
Nelfinavir—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00204	CcSEcCtD
Nelfinavir—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000307	0.00204	CcSEcCtD
Nelfinavir—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00203	CcSEcCtD
Nelfinavir—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000306	0.00203	CcSEcCtD
Nelfinavir—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000303	0.00201	CcSEcCtD
Nelfinavir—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00201	CcSEcCtD
Nelfinavir—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000302	0.002	CcSEcCtD
Nelfinavir—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.002	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.0003	0.00199	CcSEcCtD
Nelfinavir—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00198	CcSEcCtD
Nelfinavir—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00198	CcSEcCtD
Nelfinavir—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000298	0.00198	CcSEcCtD
Nelfinavir—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00197	CcSEcCtD
Nelfinavir—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.00196	CcSEcCtD
Nelfinavir—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00196	CcSEcCtD
Nelfinavir—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00195	CcSEcCtD
Nelfinavir—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00195	CcSEcCtD
Nelfinavir—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00194	CcSEcCtD
Nelfinavir—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00192	CcSEcCtD
Nelfinavir—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00191	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00189	CcSEcCtD
Nelfinavir—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00189	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000284	0.00189	CcSEcCtD
Nelfinavir—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00187	CcSEcCtD
Nelfinavir—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00184	CcSEcCtD
Nelfinavir—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.00184	CcSEcCtD
Nelfinavir—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00184	CcSEcCtD
Nelfinavir—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00184	CcSEcCtD
Nelfinavir—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00184	CcSEcCtD
Nelfinavir—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00184	CcSEcCtD
Nelfinavir—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00184	CcSEcCtD
Nelfinavir—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00183	CcSEcCtD
Nelfinavir—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00183	CcSEcCtD
Nelfinavir—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00183	CcSEcCtD
Nelfinavir—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.00183	CcSEcCtD
Nelfinavir—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.00183	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00183	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00183	CcSEcCtD
Nelfinavir—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00182	CcSEcCtD
Nelfinavir—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00182	CcSEcCtD
Nelfinavir—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000271	0.0018	CcSEcCtD
Nelfinavir—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000271	0.0018	CcSEcCtD
Nelfinavir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00179	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00179	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00179	CcSEcCtD
Nelfinavir—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00176	CcSEcCtD
Nelfinavir—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00176	CcSEcCtD
Nelfinavir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00174	CcSEcCtD
Nelfinavir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00174	CcSEcCtD
Nelfinavir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00174	CcSEcCtD
Nelfinavir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00173	CcSEcCtD
Nelfinavir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00173	CcSEcCtD
Nelfinavir—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00173	CcSEcCtD
Nelfinavir—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00172	CcSEcCtD
Nelfinavir—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00171	CcSEcCtD
Nelfinavir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00171	CcSEcCtD
Nelfinavir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00171	CcSEcCtD
Nelfinavir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00171	CcSEcCtD
Nelfinavir—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000256	0.0017	CcSEcCtD
Nelfinavir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00169	CcSEcCtD
Nelfinavir—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.00169	CcSEcCtD
Nelfinavir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00168	CcSEcCtD
Nelfinavir—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00166	CcSEcCtD
Nelfinavir—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00165	CcSEcCtD
Nelfinavir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000247	0.00164	CcSEcCtD
Nelfinavir—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00162	CcSEcCtD
Nelfinavir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00162	CcSEcCtD
Nelfinavir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00161	CcSEcCtD
Nelfinavir—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00161	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00161	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00161	CcSEcCtD
Nelfinavir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00159	CcSEcCtD
Nelfinavir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00159	CcSEcCtD
Nelfinavir—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00159	CcSEcCtD
Nelfinavir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000239	0.00158	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00157	CcSEcCtD
Nelfinavir—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00157	CcSEcCtD
Nelfinavir—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00157	CcSEcCtD
Nelfinavir—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00157	CcSEcCtD
Nelfinavir—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00157	CcSEcCtD
Nelfinavir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00156	CcSEcCtD
Nelfinavir—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00155	CcSEcCtD
Nelfinavir—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00155	CcSEcCtD
Nelfinavir—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00155	CcSEcCtD
Nelfinavir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000233	0.00155	CcSEcCtD
Nelfinavir—Injury—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00154	CcSEcCtD
Nelfinavir—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00153	CcSEcCtD
Nelfinavir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00153	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00152	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00152	CcSEcCtD
Nelfinavir—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00152	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00152	CcSEcCtD
Nelfinavir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00151	CcSEcCtD
Nelfinavir—Pain—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00151	CcSEcCtD
Nelfinavir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00151	CcSEcCtD
Nelfinavir—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00149	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00149	CcSEcCtD
Nelfinavir—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00148	CcSEcCtD
Nelfinavir—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00148	CcSEcCtD
Nelfinavir—Pain—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00148	CcSEcCtD
Nelfinavir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000222	0.00147	CcSEcCtD
Nelfinavir—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00147	CcSEcCtD
Nelfinavir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.00146	CcSEcCtD
Nelfinavir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.00146	CcSEcCtD
Nelfinavir—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00145	CcSEcCtD
Nelfinavir—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00145	CcSEcCtD
Nelfinavir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00145	CcSEcCtD
Nelfinavir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00145	CcSEcCtD
Nelfinavir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000218	0.00144	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00144	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00144	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00144	CcSEcCtD
Nelfinavir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00142	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00141	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00141	CcSEcCtD
Nelfinavir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000211	0.0014	CcSEcCtD
Nelfinavir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.0014	CcSEcCtD
Nelfinavir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00139	CcSEcCtD
Nelfinavir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00139	CcSEcCtD
Nelfinavir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00139	CcSEcCtD
Nelfinavir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00139	CcSEcCtD
Nelfinavir—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00139	CcSEcCtD
Nelfinavir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000209	0.00139	CcSEcCtD
Nelfinavir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00138	CcSEcCtD
Nelfinavir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.00138	CcSEcCtD
Nelfinavir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00138	CcSEcCtD
Nelfinavir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00137	CcSEcCtD
Nelfinavir—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00137	CcSEcCtD
Nelfinavir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000206	0.00137	CcSEcCtD
Nelfinavir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00136	CcSEcCtD
Nelfinavir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00136	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00136	CcSEcCtD
Nelfinavir—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.00135	CcSEcCtD
Nelfinavir—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00134	CcSEcCtD
Nelfinavir—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00134	CcSEcCtD
Nelfinavir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00132	CcSEcCtD
Nelfinavir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00132	CcSEcCtD
Nelfinavir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00132	CcSEcCtD
Nelfinavir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.0013	CcSEcCtD
Nelfinavir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000196	0.0013	CcSEcCtD
Nelfinavir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.0013	CcSEcCtD
Nelfinavir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00127	CcSEcCtD
Nelfinavir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00126	CcSEcCtD
Nelfinavir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00126	CcSEcCtD
Nelfinavir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00125	CcSEcCtD
Nelfinavir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00125	CcSEcCtD
Nelfinavir—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00124	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00124	CcSEcCtD
Nelfinavir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Nelfinavir—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00123	CcSEcCtD
Nelfinavir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00123	CcSEcCtD
Nelfinavir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00122	CcSEcCtD
Nelfinavir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00121	CcSEcCtD
Nelfinavir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00121	CcSEcCtD
Nelfinavir—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00018	0.0012	CcSEcCtD
Nelfinavir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00119	CcSEcCtD
Nelfinavir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000178	0.00118	CcSEcCtD
Nelfinavir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00118	CcSEcCtD
Nelfinavir—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00117	CcSEcCtD
Nelfinavir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00117	CcSEcCtD
Nelfinavir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00117	CcSEcCtD
Nelfinavir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00114	CcSEcCtD
Nelfinavir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00114	CcSEcCtD
Nelfinavir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00114	CcSEcCtD
Nelfinavir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00112	CcSEcCtD
Nelfinavir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00112	CcSEcCtD
Nelfinavir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00111	CcSEcCtD
Nelfinavir—Rash—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00111	CcSEcCtD
Nelfinavir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00111	CcSEcCtD
Nelfinavir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00111	CcSEcCtD
Nelfinavir—Headache—Formoterol—chronic obstructive pulmonary disease	0.000166	0.0011	CcSEcCtD
Nelfinavir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.0011	CcSEcCtD
Nelfinavir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.0011	CcSEcCtD
Nelfinavir—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.0011	CcSEcCtD
Nelfinavir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000165	0.0011	CcSEcCtD
Nelfinavir—Rash—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00109	CcSEcCtD
Nelfinavir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00109	CcSEcCtD
Nelfinavir—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00109	CcSEcCtD
Nelfinavir—Headache—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00108	CcSEcCtD
Nelfinavir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00106	CcSEcCtD
Nelfinavir—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00105	CcSEcCtD
Nelfinavir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00105	CcSEcCtD
Nelfinavir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00105	CcSEcCtD
Nelfinavir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00105	CcSEcCtD
Nelfinavir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00105	CcSEcCtD
Nelfinavir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00104	CcSEcCtD
Nelfinavir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00103	CcSEcCtD
Nelfinavir—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.00101	CcSEcCtD
Nelfinavir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000989	CcSEcCtD
Nelfinavir—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000984	CcSEcCtD
Nelfinavir—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000981	CcSEcCtD
Nelfinavir—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000976	CcSEcCtD
Nelfinavir—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00096	CcSEcCtD
Nelfinavir—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000955	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000923	CcSEcCtD
Nelfinavir—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000913	CcSEcCtD
Nelfinavir—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000886	CcSEcCtD
Nelfinavir—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000882	CcSEcCtD
Nelfinavir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000863	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000857	CcSEcCtD
Nelfinavir—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00085	CcSEcCtD
Nelfinavir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00085	CcSEcCtD
Nelfinavir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000816	CcSEcCtD
Nelfinavir—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000789	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000787	CcSEcCtD
Nelfinavir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000786	CcSEcCtD
Nelfinavir—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000781	CcSEcCtD
Nelfinavir—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000767	CcSEcCtD
Nelfinavir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000758	CcSEcCtD
Nelfinavir—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000736	CcSEcCtD
Nelfinavir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000724	CcSEcCtD
Nelfinavir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000724	CcSEcCtD
Nelfinavir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000721	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000719	CcSEcCtD
Nelfinavir—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000715	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000703	CcSEcCtD
Nelfinavir—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000694	CcSEcCtD
Nelfinavir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000674	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000671	CcSEcCtD
Nelfinavir—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000661	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.000632	CcSEcCtD
Nelfinavir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.51e-05	0.000631	CcSEcCtD
Nelfinavir—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.46e-05	0.000627	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000623	CcSEcCtD
Nelfinavir—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.000611	CcSEcCtD
Nelfinavir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.09e-05	0.000603	CcSEcCtD
Nelfinavir—Rash—Prednisolone—chronic obstructive pulmonary disease	9.07e-05	0.000602	CcSEcCtD
Nelfinavir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.06e-05	0.000601	CcSEcCtD
Nelfinavir—Headache—Prednisolone—chronic obstructive pulmonary disease	9.01e-05	0.000598	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.61e-05	0.000572	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.55e-05	0.000567	CcSEcCtD
Nelfinavir—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.55e-05	0.000567	CcSEcCtD
Nelfinavir—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000551	CcSEcCtD
Nelfinavir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000548	CcSEcCtD
Nelfinavir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000548	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000511	CcSEcCtD
Nelfinavir—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.5e-05	0.000498	CcSEcCtD
Nelfinavir—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.4e-05	0.000491	CcSEcCtD
Nelfinavir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.15e-05	0.000475	CcSEcCtD
Nelfinavir—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000459	CcSEcCtD
Nelfinavir—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000441	CcSEcCtD
Nelfinavir—Rash—Prednisone—chronic obstructive pulmonary disease	6.59e-05	0.000437	CcSEcCtD
Nelfinavir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.59e-05	0.000437	CcSEcCtD
Nelfinavir—Headache—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000435	CcSEcCtD
Nelfinavir—Nausea—Prednisone—chronic obstructive pulmonary disease	6.21e-05	0.000412	CcSEcCtD
Nelfinavir—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.95e-05	0.000903	CbGpPWpGaD
Nelfinavir—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.95e-05	0.000902	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	3.93e-05	0.000897	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.93e-05	0.000897	CbGpPWpGaD
Nelfinavir—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.92e-05	0.000895	CbGpPWpGaD
Nelfinavir—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.9e-05	0.00089	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	3.9e-05	0.00089	CbGpPWpGaD
Nelfinavir—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.9e-05	0.00089	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.89e-05	0.000889	CbGpPWpGaD
Nelfinavir—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.87e-05	0.000883	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.86e-05	0.000881	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	3.78e-05	0.000864	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.77e-05	0.000861	CbGpPWpGaD
Nelfinavir—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.74e-05	0.000855	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.73e-05	0.000852	CbGpPWpGaD
Nelfinavir—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.69e-05	0.000843	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.69e-05	0.000842	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.68e-05	0.000841	CbGpPWpGaD
Nelfinavir—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.63e-05	0.00083	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.6e-05	0.000823	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.6e-05	0.000823	CbGpPWpGaD
Nelfinavir—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.6e-05	0.000823	CbGpPWpGaD
Nelfinavir—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.58e-05	0.000818	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.57e-05	0.000815	CbGpPWpGaD
Nelfinavir—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.57e-05	0.000814	CbGpPWpGaD
Nelfinavir—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.55e-05	0.000811	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.53e-05	0.000807	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.53e-05	0.000807	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.53e-05	0.000806	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.52e-05	0.000804	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	3.5e-05	0.0008	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.47e-05	0.000793	CbGpPWpGaD
Nelfinavir—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.44e-05	0.000787	CbGpPWpGaD
Nelfinavir—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.41e-05	0.00078	CbGpPWpGaD
Nelfinavir—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.4e-05	0.000776	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.4e-05	0.000776	CbGpPWpGaD
Nelfinavir—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.37e-05	0.000769	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.36e-05	0.000768	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.36e-05	0.000768	CbGpPWpGaD
Nelfinavir—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.35e-05	0.000765	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.32e-05	0.000759	CbGpPWpGaD
Nelfinavir—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.3e-05	0.000754	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.28e-05	0.000749	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.26e-05	0.000744	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	3.23e-05	0.000738	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.23e-05	0.000738	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.19e-05	0.000729	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.1e-05	0.000708	CbGpPWpGaD
Nelfinavir—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.08e-05	0.000703	CbGpPWpGaD
Nelfinavir—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.06e-05	0.000698	CbGpPWpGaD
Nelfinavir—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.05e-05	0.000696	CbGpPWpGaD
Nelfinavir—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.04e-05	0.000693	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.02e-05	0.000689	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.01e-05	0.000688	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.01e-05	0.000686	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.94e-05	0.000672	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.93e-05	0.000669	CbGpPWpGaD
Nelfinavir—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.92e-05	0.000666	CbGpPWpGaD
Nelfinavir—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.88e-05	0.000657	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.8e-05	0.00064	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.79e-05	0.000638	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.77e-05	0.000633	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.75e-05	0.000627	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.73e-05	0.000624	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.000603	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.58e-05	0.00059	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.58e-05	0.000589	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.58e-05	0.000589	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.57e-05	0.000587	CbGpPWpGaD
Nelfinavir—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.55e-05	0.000582	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.51e-05	0.000573	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.42e-05	0.000552	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.39e-05	0.000546	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.39e-05	0.000545	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.38e-05	0.000542	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.35e-05	0.000536	CbGpPWpGaD
Nelfinavir—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.34e-05	0.000535	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.33e-05	0.000533	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.000514	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.23e-05	0.000509	CbGpPWpGaD
Nelfinavir—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.22e-05	0.000507	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.18e-05	0.000498	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000491	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.12e-05	0.000484	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.07e-05	0.000472	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.04e-05	0.000467	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.01e-05	0.000459	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2e-05	0.000456	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.98e-05	0.000452	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.96e-05	0.000447	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.95e-05	0.000445	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.94e-05	0.000443	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.91e-05	0.000437	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.91e-05	0.000435	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000433	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.000433	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.89e-05	0.000432	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000428	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000426	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.84e-05	0.000419	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.82e-05	0.000416	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.81e-05	0.000414	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.81e-05	0.000414	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000412	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.8e-05	0.000412	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.79e-05	0.000408	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.77e-05	0.000404	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.77e-05	0.000403	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.76e-05	0.000402	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.75e-05	0.000399	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000394	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.000392	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.000391	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000383	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.68e-05	0.000383	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.67e-05	0.000382	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.66e-05	0.000379	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.65e-05	0.000377	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.65e-05	0.000376	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.59e-05	0.000364	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000363	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.00036	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.57e-05	0.00036	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.55e-05	0.000355	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.55e-05	0.000353	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.54e-05	0.000352	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.51e-05	0.000345	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.000345	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.47e-05	0.000335	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.46e-05	0.000333	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.45e-05	0.00033	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000328	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.43e-05	0.000327	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.42e-05	0.000324	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.41e-05	0.000323	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.41e-05	0.000321	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.000321	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.39e-05	0.000317	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.37e-05	0.000313	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.36e-05	0.00031	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.35e-05	0.000308	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.33e-05	0.000303	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-05	0.000301	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.0003	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.000299	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.31e-05	0.000299	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000296	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000289	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000285	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.000283	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.22e-05	0.00028	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.000279	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000276	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.21e-05	0.000276	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.2e-05	0.000274	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.19e-05	0.000272	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.17e-05	0.000267	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000266	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000264	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000262	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.00026	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000257	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.000256	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.09e-05	0.000248	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.07e-05	0.000244	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000242	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000239	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.04e-05	0.000236	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000234	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	9.92e-06	0.000227	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.77e-06	0.000223	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.75e-06	0.000223	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.73e-06	0.000222	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.67e-06	0.000221	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.64e-06	0.00022	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.59e-06	0.000219	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.57e-06	0.000218	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.56e-06	0.000218	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.51e-06	0.000217	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.49e-06	0.000217	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.38e-06	0.000214	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.34e-06	0.000213	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.07e-06	0.000207	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.94e-06	0.000204	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.91e-06	0.000204	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.81e-06	0.000201	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.8e-06	0.000201	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.74e-06	0.0002	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.72e-06	0.000199	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.6e-06	0.000196	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	8.49e-06	0.000194	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.47e-06	0.000194	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.28e-06	0.000189	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.26e-06	0.000189	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.17e-06	0.000187	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.12e-06	0.000185	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.11e-06	0.000185	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.04e-06	0.000184	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	7.86e-06	0.000179	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	7.79e-06	0.000178	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.62e-06	0.000174	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.52e-06	0.000172	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.45e-06	0.00017	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.45e-06	0.00017	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.35e-06	0.000168	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.25e-06	0.000166	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	7.25e-06	0.000166	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.17e-06	0.000164	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.08e-06	0.000162	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.93e-06	0.000158	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.76e-06	0.000154	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.76e-06	0.000154	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.7e-06	0.000153	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.67e-06	0.000152	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.61e-06	0.000151	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.59e-06	0.000151	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.4e-06	0.000146	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.38e-06	0.000146	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.3e-06	0.000144	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.25e-06	0.000143	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.21e-06	0.000142	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.16e-06	0.000141	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.89e-06	0.000135	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.84e-06	0.000133	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	5.76e-06	0.000132	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.75e-06	0.000131	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.73e-06	0.000131	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.65e-06	0.000129	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.63e-06	0.000129	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.51e-06	0.000126	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.39e-06	0.000123	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.3e-06	0.000121	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.26e-06	0.00012	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.99e-06	0.000114	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.42e-06	0.000101	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.36e-06	9.96e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.35e-06	9.94e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.25e-06	9.7e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.16e-06	9.51e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.06e-06	9.28e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.06e-06	9.28e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4e-06	9.14e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.97e-06	9.06e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.85e-06	8.79e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.83e-06	8.75e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.8e-06	8.67e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.39e-06	7.75e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.24e-06	7.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.62e-06	5.98e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.5e-06	5.72e-05	CbGpPWpGaD
